<DOC>
	<DOC>NCT02640183</DOC>
	<brief_summary>The aim of this study is to investigate the efficacy of 5% lidocaine 25 mg-prilocaine 25 mg/g cream (EMLAÂ®) applied to the uterine cervix for reducing pain during diagnostic hysteroscopy, using a visual analogue scale (VAS) for pain, and whether it can replace general anesthesia that may be required for some cases of office hysteroscopy.</brief_summary>
	<brief_title>EMLA Cream in Hysteroscopy Practice</brief_title>
	<detailed_description />
	<mesh_term>EMLA</mesh_term>
	<criteria>1. Patients that must perform a diagnostic hysteroscopy. 2. Acceptance to participate in the study. 3. Signed informed consent. 4. Not taking analgesics (acetaminophen, ibuprofen, mefenamic acid) 6h before admission. 5. Absence of sedative use 24 h before admission 1. Hypersensitivity or allergy to anesthetics 2. refusal of the patient 3. Patients under age 18 and pregnant. 4. Patients on antiarrhythmic drugs due to possibility of drug interaction. 5. Unbearable pain that involves other analgesic measures. 6. Allergic reactions to topical anesthetics</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>